239 related articles for article (PubMed ID: 20664535)
21. [Medical treatment of Alzheimer's disease].
Johannsen P
Ugeskr Laeger; 2006 Oct; 168(40):3424-9. PubMed ID: 17032609
[TBL] [Abstract][Full Text] [Related]
22. Clinical efficacy and safety of donepezil on cognitive and global function in patients with Alzheimer's disease. A 24-week, multicenter, double-blind, placebo-controlled study in Japan. E2020 Study Group.
Homma A; Takeda M; Imai Y; Udaka F; Hasegawa K; Kameyama M; Nishimura T
Dement Geriatr Cogn Disord; 2000; 11(6):299-313. PubMed ID: 11044775
[TBL] [Abstract][Full Text] [Related]
23. [[Donepezil : a new option in the treatment of Alzheimer's disease] ONEPA].
Azanza JR; Sádaba B; Quetglas EG; Escolar M
Rev Med Univ Navarra; 1998; 42(2):109-18. PubMed ID: 10420948
[No Abstract] [Full Text] [Related]
24. Adverse effects associated with the use of donepezil in general practice in England.
Dunn NR; Pearce GL; Shakir SA
J Psychopharmacol; 2000; 14(4):406-8. PubMed ID: 11198060
[TBL] [Abstract][Full Text] [Related]
25. [Post-marketing observational study of donepezil].
Ibach B
Krankenpfl J; 2005; 43(1-3):25. PubMed ID: 15912820
[No Abstract] [Full Text] [Related]
26. Alcohol abuse in an elderly woman taking donepezil for Alzheimer disease.
Marinho V; Laks J; Engelhardt E; Conn D
J Clin Psychopharmacol; 2006 Dec; 26(6):683-5. PubMed ID: 17110839
[No Abstract] [Full Text] [Related]
27. Antidementia drug use among community-dwelling individuals with Alzheimer's disease in Finland: a nationwide register-based study.
Taipale H; Tanskanen A; Koponen M; Tolppanen AM; Tiihonen J; Hartikainen S
Int Clin Psychopharmacol; 2014 Jul; 29(4):216-23. PubMed ID: 24608822
[TBL] [Abstract][Full Text] [Related]
28. Donepezil use in the treatment of dementia associated with Down syndrome.
Cipriani G; Bianchetti A; Trabucchi M
Arch Neurol; 2003 Feb; 60(2):292; author reply 292. PubMed ID: 12580720
[No Abstract] [Full Text] [Related]
29. Donepezil-treated patients with probable vascular dementia demonstrate cognitive benefits.
Pratt RD; Perdomo CA
Ann N Y Acad Sci; 2002 Nov; 977():513-22. PubMed ID: 12480794
[No Abstract] [Full Text] [Related]
30. [Interaction of donepezil and muscular blockers in Alzheimer's disease].
Sánchez Morillo J; Demartini Ferrari A; Roca de Togores López A
Rev Esp Anestesiol Reanim; 2003 Feb; 50(2):97-100. PubMed ID: 12712872
[TBL] [Abstract][Full Text] [Related]
31. A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Down syndrome and Alzheimer's disease--pilot study.
Prasher VP; Huxley A; Haque MS;
Int J Geriatr Psychiatry; 2002 Mar; 17(3):270-8. PubMed ID: 11921156
[TBL] [Abstract][Full Text] [Related]
32. Significance of syncope in patients with Alzheimer's disease treated with cholinesterase inhibitors.
Bordier P; Garrigue S; Barold SS; Bressolles N; Lanusse S; Clémenty J
Europace; 2003 Oct; 5(4):429-31. PubMed ID: 14753643
[TBL] [Abstract][Full Text] [Related]
33. Are cholinesterase inhibitors effective in the management of the behavioral and psychological symptoms of dementia in Alzheimer's disease? A systematic review of randomized, placebo-controlled trials of donepezil, rivastigmine and galantamine.
Rodda J; Morgan S; Walker Z
Int Psychogeriatr; 2009 Oct; 21(5):813-24. PubMed ID: 19538824
[TBL] [Abstract][Full Text] [Related]
34. Donepezil and athetosis in an elderly patient with Alzheimer's disease.
Tanaka M; Yokode M; Kita T; Matsubayashi K
J Am Geriatr Soc; 2003 Jun; 51(6):889-90. PubMed ID: 12757588
[No Abstract] [Full Text] [Related]
35. Donepezil use in Alzheimer disease.
Barner EL; Gray SL
Ann Pharmacother; 1998 Jan; 32(1):70-7. PubMed ID: 9475825
[TBL] [Abstract][Full Text] [Related]
36. Clinical effects of high oral dose of donepezil for patients with Alzheimer's disease in Japan.
Nozawa M; Ichimiya Y; Nozawa E; Utumi Y; Sugiyama H; Murayama N; Iseki E; Arai H
Psychogeriatrics; 2009 Jun; 9(2):50-5. PubMed ID: 19604325
[TBL] [Abstract][Full Text] [Related]
37. Cholinesterase inhibitors and incidence of bradycardia in patients with dementia in the veterans affairs new England healthcare system.
Hernandez RK; Farwell W; Cantor MD; Lawler EV
J Am Geriatr Soc; 2009 Nov; 57(11):1997-2003. PubMed ID: 19793162
[TBL] [Abstract][Full Text] [Related]
38. Donepezil effects on hippocampal and prefrontal functional connectivity in Alzheimer's disease: preliminary report.
Zaidel L; Allen G; Cullum CM; Briggs RW; Hynan LS; Weiner MF; McColl R; Gopinath KS; McDonald E; Rubin CD
J Alzheimers Dis; 2012; 31 Suppl 3(0 3):S221-6. PubMed ID: 22886013
[TBL] [Abstract][Full Text] [Related]
39. Beyond symptomatic effects: potential of donepezil as a neuroprotective agent and disease modifier in Alzheimer's disease.
Kim SH; Kandiah N; Hsu JL; Suthisisang C; Udommongkol C; Dash A
Br J Pharmacol; 2017 Dec; 174(23):4224-4232. PubMed ID: 28901528
[TBL] [Abstract][Full Text] [Related]
40. Donepezil for dementia due to Alzheimer's disease.
Birks J; Harvey RJ
Cochrane Database Syst Rev; 2006 Jan; (1):CD001190. PubMed ID: 16437430
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]